Russian Open Medical Journal · Published 2026-03-31 · DOI 10.15275/rusomj.2026.0107
Background — C-reactive protein (CRP) and cancer antigen 15-3 (CA 15-3) are commonly studied biomarkers in breast cancer, but their prognostic significance at diagnosis remains unclear. Aim: Our study aimed to assess the prognostic value of serum CRP and CA 15-3 levels in newly diagnosed breast cancer patients. Methods — We enrolled 39 patients with primary breast cancer in our single-center study. Serum CRP and CA 15-3 levels were measured at diagnosis. Receiver operating characteristic (ROC) analysis was employed to determine optimal cut-off values. Survival outcomes were analyzed. Results — Elevated CRP and CA 15-3 levels were associated with shorter progression-free survival and overall survival. In particular, CRP demonstrated significant prognostic value. However, due to the critically small sample size, the obtained results should be considered preliminary. Conclusion — Serum CRP and CA 15-3 levels may serve as potential prognostic markers in breast cancer. These results are hypothetical and require confirmation in larger cohorts.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →